According to the status of estrogen receptor (ER), progesterone receptor (PR), ki-67, and HER-2 expression, breast cancer can be classified into four molecular subtypes: Luminal A, Luminal B, HER-2 over-expression, and triple-negative breast cancer. Here, ESR1 is linked to triple-negative breast carcinoma.